PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Donald E Tsai Selected Research
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2007
Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
04/2006
Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
12/2005
Post-transplant lymphoproliferative disorder.
10/2005
Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.
08/2005
Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene.
10/2003
Use of serum protein electrophoresis to monitor patients with post-transplant lymphoproliferative disorder.
11/2002
Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.
Articles by Research Topic
Disease
7
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2007 - 11/2002
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2007 - 06/2003
3
Lymphoma (Lymphomas)
09/2005 - 06/2003
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2008 - 01/2007
1
Hypertriglyceridemia
03/2008
1
Infection
09/2005
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2005
1
Pericardial Effusion
09/2005
1
Hyperplasia
06/2004
1
Hodgkin Disease (Hodgkin's Disease)
06/2004
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2004
1
Neoplasms (Cancer)
12/2003
1
Syndrome
06/2003
Drug/Important Bio-Agent (IBA)
4
rituximab (Mabthera)
FDA Link
10/2007 - 06/2003
3
bexarotene (LGD1069)
FDA Link
09/2008 - 08/2005
1
Hemoglobins (Hemoglobin)
IBA
03/2008
1
Toll-Like Receptor 9
IBA
10/2007
1
Retinoid X Receptors (Retinoid X Receptor)
IBA
01/2007
1
gemcitabine
FDA Link
09/2005
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
06/2004
1
Iodine
IBA
03/2004
1
Immunoglobulin G (IgG)
IBA
12/2003
1
hLL2 agent (epratuzumab)
IBA
12/2003
1
ibritumomab tiuxetan (Zevalin)
FDA Link
06/2003
Therapy/Procedure
6
Transplants (Transplant)
04/2006 - 11/2002
3
Radioimmunotherapy
03/2004 - 06/2003
2
Aftercare (After-Treatment)
09/2005 - 09/2005
1
Transplantation (Transplant Recipients)
05/2007